Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study.

Details

Ressource 1Download: 35564733_BIB_9A80E8D0D202.pdf (663.53 [Ko])
State: Public
Version: Final published version
License: CC BY 4.0
Serval ID
serval:BIB_9A80E8D0D202
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study.
Journal
International journal of environmental research and public health
Author(s)
Gerbier E., Favre G., Tauqeer F., Winterfeld U., Stojanov M., Oliver A., Passier A., Nordeng H., Pomar L., Baud D., Panchaud A., Meyer-Massetti C., Ceulemans M.
ISSN
1660-4601 (Electronic)
ISSN-L
1660-4601
Publication state
Published
Issued date
27/04/2022
Peer-reviewed
Oui
Volume
19
Number
9
Pages
5335
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
Abstract
Information on medication utilization among pregnant and postpartum women during the pandemic is lacking. We described the prevalence and patterns of self-reported medication use among pregnant and postpartum women during the third wave of the pandemic (June-August 2021). An online questionnaire was distributed in five European countries between June-August 2021. Pregnant women or women who had delivered in the three preceding months, and ≥18 years old, could participate. The prevalence of overall medication use, self-medication, and changes in chronic medication use were determined. A total of 2158 women out of 5210 participants (41.4%) used at least one medication. Analgesics (paracetamol), systemic antihistamines (cetirizine), and drugs for gastric disorders (omeprazole) were the three most used classes. Anti-infectives were less prevalent than during pre-pandemic times. Antidepressants and anxiety related medication use remained similar, despite a higher prevalence of these symptoms. Self-medication was reported in 19.4% of women, and 4.1% of chronic medication users reported that they changed a chronic medication on personal initiative due to the pandemic. In conclusion, medication use patterns in our cohort were mostly similar to those of the first COVID-19 wave and the pre-pandemic period. More studies are needed to explore factors associated with self-medication and changes in chronic medication use due to the pandemic in this perinatal population.
Keywords
Adolescent, Anxiety/epidemiology, COVID-19/drug therapy, COVID-19/epidemiology, Cross-Sectional Studies, Female, Humans, Pandemics, Parturition, Postpartum Period, Pregnancy, Pregnant Women, Self Report, COVID-19, Europe, chronic disease, drug utilization, medication use, pandemic, pharmacoepidemiology, postpartum, pregnancy, self-medication
Pubmed
Web of science
Open Access
Yes
Create date
23/05/2022 14:12
Last modification date
23/01/2024 8:31
Usage data